Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.
NCT ID: NCT06912802
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
350 participants
OBSERVATIONAL
2025-07-29
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Myopia Acquisition and Prevention
NCT00477620
Real-World Study of Myopia Prevention and Control in Children
NCT06849895
Incidence of Myopia in a Prospective Cohort of Emmetropic Children and Associated Ocular and Environmental Factors
NCT07316998
Evolution of Ocular Growth in Myopic Children: A Prospective Cohort Study
NCT06895044
Environmental Health and Myopia Prevention and Control
NCT04161326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Childhood Myopia
Parents (or other proxy) of children or adolescents aged 5 years or older suffering from myopia (low, moderate, or high myopia) defined by their refractive error;
Non-Intervention
Non-Intervention study
Adulthood Myopia + Long-Term Complication
Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.
Non-Intervention
Non-Intervention study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Intervention
Non-Intervention study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults suffering from myopia and its complications such as: cataract, macular degeneration, open-angle glaucoma, retinal detachment, and legal blindness/severe visual impairment.
* Patients where myopia is a known or likely contributing factor to the complication.
Exclusion Criteria
* Patients where the complication is likely unrelated to myopia (e.g., cataract caused by diabetes) will be excluded
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santen SAS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital
Copenhagen, , Denmark
University Hospital Necker Enfants Malades
Paris, , France
Klinik für Augenheilkunde (Universitätsklinikum Freiburg)
Freiburg im Breisgau, , Germany
Universitäts-Augenklinik Mainz
Mainz, , Germany
Meyer Children's Hospital IRCCS
Florence, , Italy
Policlinico Universitario Agostino Gemelli IRCCS
Rome, , Italy
Estudio Oftalmologico
Madrid, , Spain
The San Carlos Clinic Hospital (Hospital Clinico San Carlos-HCSC)
Madrid, , Spain
St. Erik Eye Hospital
Solna, , Sweden
Moorfields Eye Hospital NHS Foundation Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Prof. Kessel
Role: primary
Dr. Bremond-Gignac
Role: primary
Dr. Wolf Lagrèze
Role: primary
Dr. Alexander Schuster
Role: primary
Prof Caputo
Role: primary
Dr. Rizzo
Role: primary
Dr. Donate
Role: primary
Dr. Guemes
Role: primary
Dr. Epstein
Role: primary
Dr. Lofgren
Role: backup
Dr. Annegret Dahlmann-Noor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PMA-HEOR-QoL-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.